AbbVie Demonstrates Leadership in HCV with New MAVYRET (glecaprevir/pibrentasvir) Data to be Presented at The Liver Meeting® 2017

Press/Media: Press / Media

PeriodOct 11 2017 → Oct 12 2017

Media coverage

5

Media coverage

  • TitleAbbVie Demonstrates Leadership in HCV with New MAVYRET (glecaprevir/pibrentasvir) Data to be Presented at The Liver Meeting® 2017
    Media name/outletPlus Company Updates (PCU)
    CountryUnited States
    Date10/12/17
    PersonsFred Poordad
  • TitleAbbVie Demonstrates Leadership in HCV with New MAVYRET (glecaprevir/pibrentasvir) Data to be Presented at The Liver Meeting® 2017
    Media name/outletDigital Producer
    CountryUnited States
    Date10/11/17
    PersonsFred Poordad
  • TitleAbbVie Demonstrates Leadership in HCV with New MAVYRET (glecaprevir/pibrentasvir) Data to be Presented at The Liver Meeting® 2017
    Media name/outletDigital Media Net
    CountryUnited States
    Date10/11/17
    PersonsFred Poordad
  • TitleAbbVie Demonstrates Leadership in HCV with New MAVYRET (glecaprevir/pibrentasvir) Data to be Presented at The Liver Meeting® 2017
    Media name/outletVideoBasedTutorials
    CountryUnited States
    Date10/11/17
    PersonsFred Poordad
  • TitleAbbVie Demonstrates Leadership in HCV with New MAVYRET (glecaprevir/pibrentasvir) Data to be Presented at The Liver Meeting® 2017
    Media name/outletPresentation Master
    CountryUnited States
    Date10/11/17
    PersonsFred Poordad